Literature DB >> 35855841

Efficacy and Safety of Tripterygium Wilfordii Glycoside Tablets Combined with Acitretin Capsules in the Treatment of Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial.

Qinghui Fu1, Yunjie Zhu2, Yiqi Fang3, Changbo Dai4.   

Abstract

Objective: To probe into the clinical efficacy of tripterygium wilfordii glycoside (TWGs) tablets combined with acitretin capsules in the treatment of patients with moderate to severe plaque psoriasis (MSPP).
Methods: Thirty-six patients with MSPP were collected and divided into three groups, namely, group A (n = 12, TWG tablets + acitretin capsules), group B (n = 12, compound glycyrrhizin capsules + acitretin capsules), and group C (n = 12, acitretin capsules). The general data of the patients was recorded. In addition, a comparison was made before treatment, 4 weeks and 8 weeks after treatment in terms of the clinical efficacy, liver function indicators (alanine aminotransferase (ALT), aspartate transaminase (AST), and creatinine), psoriasis area, and severity index (PASI) scores. The incidence of adverse reactions after treatment and the recurrence rate during two months of follow-up was statistically analyzed.
Results: The therapeutic effect of group A was superior to the other two groups, with obviously more satisfactory results of serum parameters, clinical efficacy and PASI score, and incidence of adverse reactions. Conclusions: TWGs combined with acitretin had better therapeutic effects and higher safety in the treatment of MSPP.
Copyright © 2022 Qinghui Fu et al.

Entities:  

Year:  2022        PMID: 35855841      PMCID: PMC9288343          DOI: 10.1155/2022/2252500

Source DB:  PubMed          Journal:  Appl Bionics Biomech        ISSN: 1176-2322            Impact factor:   1.664


  24 in total

Review 1.  Generalized pustular psoriasis: a review and update on treatment.

Authors:  K M Hoegler; A M John; M Z Handler; R A Schwartz
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-04-11       Impact factor: 6.166

2.  Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.

Authors:  Jasvinder A Singh; Gordon Guyatt; Alexis Ogdie; Dafna D Gladman; Chad Deal; Atul Deodhar; Maureen Dubreuil; Jonathan Dunham; M Elaine Husni; Sarah Kenny; Jennifer Kwan-Morley; Janice Lin; Paula Marchetta; Philip J Mease; Joseph F Merola; Julie Miner; Christopher T Ritchlin; Bernadette Siaton; Benjamin J Smith; Abby S Van Voorhees; Anna Helena Jonsson; Amit Aakash Shah; Nancy Sullivan; Marat Turgunbaev; Laura C Coates; Alice Gottlieb; Marina Magrey; W Benjamin Nowell; Ana-Maria Orbai; Soumya M Reddy; Jose U Scher; Evan Siegel; Michael Siegel; Jessica A Walsh; Amy S Turner; James Reston
Journal:  Arthritis Rheumatol       Date:  2018-11-30       Impact factor: 10.995

3.  Impaired motility and random migration of vital polymorphonuclears in vitro after therapy with oral aromatic retinoid in psoriasis.

Authors:  R Bauer; R Schütz; C E Orfanos
Journal:  Int J Dermatol       Date:  1984 Jan-Feb       Impact factor: 2.736

4.  Psoriasis in monozygotic twins: variations in expression in individuals with identical genetic constitution.

Authors:  F Brandrup; N Holm; N Grunnet; K Henningsen; H E Hansen
Journal:  Acta Derm Venereol       Date:  1982       Impact factor: 4.437

Review 5.  Highly Effective New Treatments for Psoriasis Target the IL-23/Type 17 T Cell Autoimmune Axis.

Authors:  Jaehwan Kim; James G Krueger
Journal:  Annu Rev Med       Date:  2016-09-23       Impact factor: 13.739

6.  Low-dose acitretin in treatment of plaque-type psoriasis: descriptive study of efficacy and safety.

Authors:  Alessandro Borghi; Monica Corazza; Alberto Maria Bertoldi; Francesca Caroppo; Annarosa Virgili
Journal:  Acta Derm Venereol       Date:  2015-03       Impact factor: 4.437

7.  Age- and sex-adjusted prevalence estimates among adults with psoriasis in the United States.

Authors:  Zaeem Nazir; Andrew Strunk; Amit Garg
Journal:  J Am Acad Dermatol       Date:  2021-03-08       Impact factor: 11.527

8.  Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.

Authors:  Jingxia Zhao; Tingting Di; Yan Wang; Xin Liu; Daiying Liang; Guangzhong Zhang; Ping Li
Journal:  Int J Mol Med       Date:  2016-07-11       Impact factor: 4.101

Review 9.  Global epidemiology of psoriasis: a systematic review of incidence and prevalence.

Authors:  Rosa Parisi; Deborah P M Symmons; Christopher E M Griffiths; Darren M Ashcroft
Journal:  J Invest Dermatol       Date:  2012-09-27       Impact factor: 8.551

10.  Effect of Triptolide on Dextran Sodium Sulfate-Induced Ulcerative Colitis and Gut Microbiota in Mice.

Authors:  Hao Wu; Quan Rao; Guang-Chao Ma; Xiao-Hong Yu; Cong-En Zhang; Zhi-Jie Ma
Journal:  Front Pharmacol       Date:  2020-01-29       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.